Immediate Impact
2 from Science/Nature 67 standout
Citing Papers
Sotorasib with panitumumab in chemotherapy-refractory KRASG12C-mutated colorectal cancer: a phase 1b trial
2024 Standout
Sotorasib plus Panitumumab in Refractory Colorectal Cancer with Mutated KRAS G12C
2023 Standout
Works of M. Neubauer being referenced
Panitumumab antitumor activity in patients (pts) with metastatic colorectal cancer (mCRC) expressing ≥ 10% epidermal growth factor receptor (EGFr)
2006
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| M. Neubauer | 192 | 177 | 47 | 20 | 296 | |
| Vildan Kaya | 156 | 87 | 40 | 25 | 287 | |
| Camilla Delli Paoli | 134 | 109 | 22 | 22 | 277 | |
| Liberato Di Lullo | 189 | 109 | 30 | 24 | 319 | |
| Prashant Gabani | 147 | 179 | 28 | 27 | 327 | |
| Vijai Simha | 85 | 91 | 22 | 24 | 208 | |
| Ye Tian | 132 | 92 | 43 | 23 | 304 | |
| Antonella Fontana | 69 | 147 | 26 | 26 | 286 | |
| Shireen Parsai | 116 | 165 | 14 | 27 | 250 | |
| Agnieszka Zając | 75 | 138 | 124 | 21 | 291 | |
| Ramón Barceló | 152 | 156 | 29 | 27 | 282 |
All Works
Login with ORCID to disown or claim papers
Loading papers...